Insider · CIK 0001216074

LAMATTINA JOHN L

Reports to the SEC for 7 companies · JUPITER, FL

sec.gov

Transactions

Companies

Filings

CIK

0001216074

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−3,405 sh	$251.62	−$857K	26,969
2026-06-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−697 sh	$249.53	−$174K	30,374
2026-06-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−232 sh	$248.11	−$57.6K	31,071
2026-06-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−257 sh	$247.22	−$63.5K	31,303
2026-06-05	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+836 sh	—	—	31,560
2026-06-05	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,938 sh	—	—	2,938
2026-03-06	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,161 sh	$114.15	+$247K	32,885
2026-03-06	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,161 sh	$200.76	−$434K	30,724
2026-03-06	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,161 sh	—	—	0
2025-11-07	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,145 sh	$205.45	−$441K	30,724
2025-11-07	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,145 sh	$66.13	+$142K	32,869
2025-11-07	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,034 sh	$69.51	+$141K	32,758
2025-11-07	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,034 sh	$205.45	−$418K	30,724
2025-11-07	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,034 sh	—	—	0
2025-11-07	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,145 sh	—	—	0
2025-06-06	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,783 sh	—	—	5,783
2025-06-06	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,209 sh	—	—	30,724
2024-11-27	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,406 sh	—	—	0
2024-11-27	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,406 sh	$123.65	−$298K	29,515
2024-11-27	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,406 sh	$52.30	+$126K	31,921
2024-06-14	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,444 sh	—	—	5,444
2024-06-14	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,252 sh	—	—	29,515
2023-06-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,461 sh	—	—	5,461
2023-06-09	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,142 sh	—	—	28,263
2023-06-08	IMNMImmunome Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2023-01-15	IMNMImmunome Inc.A Award	Director	AAward	+15.1K sh	$4.00	+$60.5K	66,953
2022-12-22	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+4,484 sh	—	—	4,484
2022-06-16	IMNMImmunome Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2022-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+4,340 sh	—	—	4,340
2022-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+1,004 sh	—	—	26,402
2021-11-16	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,835 sh	—	—	0
2021-11-16	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−4,835 sh	$161.86	−$783K	25,398
2021-11-16	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,835 sh	$32.30	+$156K	30,233
2021-06-04	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+3,269 sh	—	—	3,269
2021-06-04	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+630 sh	—	—	25,398
2021-05-28	IMNMImmunome Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2021-05-24	IMNMImmunome Inc.P Purchase	Director	PPurchase	+5,102 sh	$18.58	+$94.8K	51,828
2021-05-24	IMNMImmunome Inc.P Purchase	Director	PPurchase	+338 sh	$18.44	+$6,232.72	46,726
2020-11-03	IMNMImmunome Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-10-06	IMNMImmunome Inc. · Warrant (right to buy)C Conversion	Director	CConversion	+11.1K sh	—	—	11,111
2020-10-06	IMNMImmunome Inc. · Warrant (right to buy)C Conversion	Director	CConversion	−11.1K sh	—	—	0
2020-10-06	IMNMImmunome Inc.C Conversion	Director	CConversion	+46.4K sh	—	—	46,388
2020-10-06	IMNMImmunome Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−46.4K sh	—	—	0
2020-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,468 sh	—	—	2,468
2020-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+831 sh	—	—	24,768
2019-08-01	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	4,835
2019-08-01	LGNDLIGAND PHARMACEUTICALS INCF Tax Payment	Director	FTax Payment	−847 sh	$95.58	−$81K	23,937
2019-08-01	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$32.30	+$80.8K	24,784
2019-06-26	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2019-06-06	LGNDLIGAND PHARMACEUTICALS INCA Award	Director	AAward	+835 sh	—	—	22,284

Recent filings

Accepted (ET)
Jun 124
LAMATTINA JOHN L0002001011-26-000102
SEC(opens sec.gov)
Jun 94
LAMATTINA JOHN L0002001011-26-000099
SEC(opens sec.gov)
Mar 314
LAMATTINA JOHN L0002001011-26-000036
SEC(opens sec.gov)
Nov 124
LAMATTINA JOHN L0002001011-25-000097
SEC(opens sec.gov)
Jun 104
LAMATTINA JOHN L0002001011-25-000044
SEC(opens sec.gov)
Dec 24
LAMATTINA JOHN L0002001011-24-000093
SEC(opens sec.gov)

Companies

Address

555 HERITAGE DRIVE SUITE 200

JUPITER, FL, 33458